ANN ARBOR, Mich., March 07, 2018 -- Duo Security, the leader in Trusted Access, and DrFirst, the market leader in e-prescribing and medication management solutions, today announced native integration of Duo’s flagship two-factor authentication (2FA) security technology with DrFirst’s hallmark e-prescription system for controlled substances, EPCS Gold. With Duo’s integration into DrFirst’s EPCS Gold, doctors can send e-prescriptions to pharmacies by approving a quick push notification on their mobile phones, satisfying DEA requirements for a separate “token” or authenticator. This helps healthcare providers meet e-prescription for controlled substances (EPCS) requirements and prevent fraudulent prescriptions with an added layer of security.
More than 350 electronic medical records (EMR) systems, 100,000 healthcare providers, 1,300 hospitals and 21,000 ambulatory facilities use DrFirst to help manage their e-prescriptions. DrFirst’s EPCS Gold, when combined with state-based prescription drug monitoring program (PDMP) access, enables clinical staff to quickly and easily identify doctor shoppers, address the issue and ensure the right medications get to the right patient. DrFirst and Duo also provide an easy-to-use solution for hospitals who are part of an integrated delivery network (IDN).
“2FA is becoming standard across the healthcare industry to ensure your users are who they say they are, whether they’re logging into your payroll software or approving an e-prescription for a controlled substance,” said Dr. Tom Sullivan, a board-certified specialist in cardiology and internal medicine with over 40 years of clinical practice. “With Duo, even if someone is able to steal a physician’s username and password, or impersonate them, Duo’s extra layer of security helps prevent the controlled substance from being sent, and immediately notifies Duo administrators of the fraudulent request.”
Duo’s ease of deployment and use is why more than 250,000 physicians currently use the product, including hundreds of top healthcare organizations such as Sentara Healthcare. At half the cost of similar products, Duo has no hardware deployment, complex software configurations nor manual setup, allowing 75 percent of organizations who use Duo to get up and running in less than a week.
Recent studies show 45 million e-prescriptions for controlled substances were delivered in 2016, a 256 percent increase from the year prior. EPCS and supporting clinical apps have been shown to increase patient adherence to medications, reduce error and fraud in prescriptions and improve patient health outcomes.
“Reducing fraud has become a focal point for healthcare providers who realize they play an integral part in helping prevent the current opioid epidemic affecting our communities,” said Doug Copley, Duo Advisory CISO, Healthcare. “Duo and DrFirst give physicians the ability to securely e-prescribe without cumbersome steps such as manually typing in a code sent through an SMS message or using a physical token.”
For more information, please visit https://duo.com/blog/duo-partners-with-drfirst-to-help-meet-epcs-requirements.
About Duo Security
Duo helps defend organizations against breaches through its easy and effective cloud-based Trusted Access product suite. The company verifies the identity of users and the health of their devices before granting them access to applications. Duo’s intentional balance of security and usability has led the company to be a trusted partner to thousands of customers worldwide, including Dresser-Rand, Etsy, Facebook, K-Swiss, Random House, Yelp, Zillow, Paramount Pictures, and more. The Ann Arbor, Michigan-based company maintains offices in Austin, Texas; San Mateo, California; and London. Visit duo.com to find out more.
About DrFirst
DrFirst, the nation’s leading provider of e-prescribing and medication management solutions, enables stakeholders across the healthcare industry to intelligently utilize comprehensive real-time data and connectivity to increase their patient safety ratings, efficiency and profitability. Today, over 170,000 healthcare professionals and over 60% of Electronic Health Record vendors, depend on DrFirst’s innovative software solutions to improve clinical workflows, expedite secure collaboration across a patient’s care team and drive better health outcomes. The company’s integrated technologies include its award-winning electronic prescribing platform, the most comprehensive medication history available, clinically specialized secure messaging, as well as patient medication adherence monitoring and benefits checking. In addition, DrFirst was the first to offer e-prescribing for controlled substances (EPCS), and is considered the industry standard for providers nationwide. For more information, please visit www.drfirst.com or connect with us @DrFirst.
Press Contact
Meredith Corley & Jordan Fylonenko
Duo Security
[email protected]


Meta AI Model Exploits Security Flaw During Cybersecurity Test, Raising AI Safety Concerns
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
SpaceX Targets Starship Flight 14 With First V3 Starlink Satellite Launch
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings
Nintendo Shares Jump as Switch 2 Sales Boost Earnings
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management 



